Maria M Simile Selected Research

Maria M Simile Research Topics

Disease

18	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 06/2002
12	Neoplasms (Cancer) 01/2023 - 07/2002
7	Carcinogenesis 01/2022 - 02/2005
7	Liver Neoplasms (Liver Cancer) 04/2019 - 03/2004
3	Genetic Predisposition to Disease (Genetic Predisposition) 12/2022 - 11/2002
3	Genomic Instability 01/2022 - 12/2007
2	Fatty Liver 01/2022 - 06/2019
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 11/2007
2	Hepatitis 01/2022 - 06/2019
1	Non-alcoholic Fatty Liver Disease 01/2022
1	Osteosarcoma (Osteogenic Sarcoma) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Intrahepatic Cholestasis 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 06/2019
1	Infections 06/2019
1	Liver Diseases (Liver Disease) 06/2019
1	Reperfusion Injury 06/2019
1	Chronic Hepatitis B 06/2019
1	Cholangiocarcinoma 12/2017
1	Adenocarcinoma 11/2007
1	Carcinoma (Carcinomatosis) 02/2005
1	Iron Overload 11/2002

Drug/Important Bio-Agent (IBA)

5	S-Adenosylmethionine (Ademetionine)IBA 01/2022 - 07/2002
4	Methionine (L-Methionine)FDA Link 01/2022 - 12/2007
4	Proteins (Proteins, Gene)FDA Link 04/2019 - 06/2008
3	DNA (Deoxyribonucleic Acid)IBA 12/2007 - 07/2002
2	Gemcitabine FDA Link 01/2022 - 12/2017
2	Therapeutic UsesIBA 01/2022 - 03/2004
2	IsoenzymesIBA 04/2019 - 07/2012
2	Mechanistic Target of Rapamycin Complex 1IBA 12/2017 - 10/2017
2	Phosphotransferases (Kinase)IBA 12/2017 - 08/2008
2	UbiquitinIBA 03/2010 - 06/2008
2	Ligases (Synthetase)IBA 03/2010 - 06/2008
2	Transforming Growth Factor alpha (TGF-alpha)IBA 08/2008 - 12/2007
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2008 - 06/2008
2	NF-kappa B (NF-kB)IBA 08/2008 - 02/2005
2	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 07/2002 - 06/2002
1	Mitogen-Activated Protein KinasesIBA 11/2023
1	Eukaryotic Initiation Factor-4A (Eukaryotic Initiation Factor 4A)IBA 01/2023
1	MTOR InhibitorsIBA 01/2023
1	Betaine (C.B.B.)FDA Link 01/2022
1	Decitabine FDA Link 01/2022
1	Ribavirin (Virazole)FDA LinkGeneric 01/2022
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	InterferonsIBA 01/2022
1	Vitamin E FDA LinkGeneric 01/2022
1	Antiviral Agents (Antivirals)IBA 06/2019
1	EnzymesIBA 06/2019
1	MicroRNAs (MicroRNA)IBA 06/2019
1	Messenger RNA (mRNA)IBA 04/2019
1	Glycine N-Methyltransferase (Glycine Sarcosine N-Methyltransferase)IBA 09/2018
1	Sirolimus (Rapamycin)FDA Link 09/2018
1	Staphylococcal Protein A (Protein A)IBA 09/2018
1	Carrier Proteins (Binding Protein)IBA 09/2018
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 09/2018
1	Mechanistic Target of Rapamycin Complex 2IBA 12/2017
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2017
1	sapanisertibIBA 12/2017
1	TOR Serine-Threonine KinasesIBA 10/2017
1	CateninsIBA 03/2017
1	LipidsIBA 03/2017
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 03/2017
1	Long Noncoding RNAIBA 05/2016
1	Small Interfering RNA (siRNA)IBA 02/2016
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2008
1	Dual Specificity Phosphatase 1IBA 06/2008
1	Protein Kinases (Protein Kinase)IBA 06/2008
1	S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA 06/2008
1	beta CateninIBA 11/2007
1	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 11/2007
1	Gonadal Steroid Hormones (Sex Hormones)IBA 11/2006
1	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2005
1	RetinoidsIBA 02/2005
1	FenretinideIBA 02/2005
1	Liposomes (Liposome)IBA 02/2005
1	Cyclin D1IBA 03/2004
1	NucleotidesIBA 03/2004
1	Stearoyl-CoA DesaturaseIBA 11/2002
1	Peroxisome ProliferatorsIBA 11/2002
1	Dichloroacetic AcidIBA 11/2002
1	CarcinogensIBA 07/2002

Therapy/Procedure

2	Therapeutics 12/2022 - 06/2019
1	Liver Transplantation 01/2023
1	Hepatectomy 06/2019
1	Drug Therapy (Chemotherapy) 12/2017